TNF-α transgenic and knockout models of CNS inflammation and degeneration
暂无分享,去创建一个
G. Kollias | K. Akassoglou | M. Pasparakis | L. Probert | L. Alexopoulou | G. Kassiotis | L Probert | K Akassoglou | G Kassiotis | M Pasparakis | L Alexopoulou | G Kollias | G. Kollias | Lesley Probert | K. Akassoglou | Manolis Pasparakis | Lena Alexopoulou
[1] J. Louis,et al. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death , 1993, Science.
[2] C. Perez,et al. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNF , 1988, Cell.
[3] A. Fontana,et al. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis , 1995, Nature Medicine.
[4] P. Linsley,et al. Costimulator B7-1 confers antigen-presenting-cell function to parenchymal tissue and in conjunction with tumor necrosis factor alpha leads to autoimmunity in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] C. Saper,et al. Distribution and characterization of tumor necrosis factor‐α‐like immunoreactivity in the murine central nervous system , 1993 .
[6] L. Gooding,et al. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact , 1990, Cell.
[7] George Kollias,et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor , 1995, Cell.
[8] G. Kollias,et al. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. , 1997, Journal of immunology.
[9] M. Mattson,et al. Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.
[10] K. Frei,et al. Antigen presentation and tumor cytotoxicity by interferon‐γ‐treated microglial cells , 1987 .
[11] R. Ransohoff,et al. Chemokines in immune-mediated inflammation of the central nervous system. , 1996, Cytokine & growth factor reviews.
[12] G. Kollias,et al. Tumour necrosis factors in immune regulation: everything that's interesting is...new! , 1996, Cytokine & growth factor reviews.
[13] E. Chen,et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[14] M. Ballestas,et al. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes , 1994, Journal of Neuroimmunology.
[15] M. Hart,et al. CNS antigen presentation , 1995, Trends in Neurosciences.
[16] M. Shin,et al. Production of cytotoxic factor for oligodendrocytes by stimulated astrocytes. , 1987, Journal of immunology.
[17] V. Perry,et al. Inflammation in the nervous system , 1995, Current Opinion in Neurobiology.
[18] R. Davis,et al. Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Cross,et al. Anti—tumor necrosis factor therapy abrogates autoimmune demyelination , 1991, Annals of neurology.
[20] D. Kioussis,et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. , 1991, The EMBO journal.
[21] D. Kioussis,et al. Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. , 1993, Journal of immunology.
[22] R. Clark,et al. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis , 1990, The Journal of experimental medicine.
[23] K. Frei,et al. Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10 , 1993, The Journal of experimental medicine.
[24] G. Kollias,et al. Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[25] C. Raine. Multiple sclerosis: TNF revisited, with promise , 1995, Nature Medicine.
[26] B. Scallon,et al. Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[27] C. Brosnan,et al. Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. , 1991, Journal of Immunology.
[28] A. Mantovani,et al. Re-evaluation of the chemotactic activity of tumour necrosis factor for monocytes. , 1990, Immunology.
[29] C. Brosnan,et al. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. , 1990, Journal of immunology.
[30] G. Kollias,et al. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. , 1996, Journal of inflammation.
[31] R. Flavell,et al. Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. , 1993, Journal of immunology.
[32] P. Vassalli,et al. Tumor‐Necrosis Factor and other Cytokines in Cerebral Malaria: Experimental and Clinical Data , 1989, Immunological reviews.
[33] J. Merrill. Effects of interleukin-1 and tumor necrosis factor-alpha on astrocytes, microglia, oligodendrocytes, and glial precursors in vitro. , 1991, Developmental neuroscience.
[34] L. Steinman,et al. The T lymphocyte in experimental allergic encephalomyelitis. , 1990, Annual review of immunology.
[35] M. Ueffing,et al. Critical involvement of transmembrane tumor necrosis factor-alpha in endothelial programmed cell death mediated by ionizing radiation and bacterial endotoxin. , 1995, Blood.
[36] R. Zinkernagel,et al. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients , 1988, The Journal of experimental medicine.
[37] G. Duff,et al. Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. , 1995, Journal of inflammation.
[38] M. Mattson,et al. Altered neuronal and microglial responses to excitotoxic and ischemic brain injury in mice lacking TNF receptors , 1996, Nature Medicine.
[39] D. Barten,et al. Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis , 1994, Journal of Neuroimmunology.
[40] W. Fiers,et al. Two tumour necrosis factor receptors: structure and function. , 1995, Trends in cell biology.
[41] R. Zinkernagel,et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes , 1993, Nature.
[42] M. Shin,et al. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[43] G. Kollias,et al. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.
[44] K. Selmaj,et al. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.
[45] K. Selmaj,et al. Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I , 1995, Journal of Neuroimmunology.
[46] R. Strieter,et al. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells , 1995, Journal of Neuroimmunology.
[47] B. Scallon,et al. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteins , 1994, European journal of immunology.
[48] D. Ferrari,et al. Activation of microglial cells by β-amyloid protein and interferon-γ , 1995, Nature.
[49] L. Ignarro,et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. , 1993, Journal of immunology.
[50] C. Raine,et al. Cytokines up-regulate Ia expression in organotypic cultures of central nervous system tissue , 1989, Journal of Neuroimmunology.
[51] R. Janzer,et al. Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.
[52] L. Orci,et al. Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes , 1992, The Journal of experimental medicine.
[53] L. Steinman,et al. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen , 1993, Nature.